Acute actions sulfonylurea drugs long-term treatment NIDDM acute effect sulfonylurea drugs long-term treatment separate studies first study levels plasma glucose insulin C-peptide intake mg glyburide standardized mixed meal non-insulin-dependent diabetes NIDDM patients mg glyburide/day yr acute effect glyburide insulin C-peptide responses meal continued fasting absence acute insulinotropic action glyburide chronic treatment glucose increase meal unchanged significant glucose reduction glyburide intake continued fasting acute extrapancreatic hepatic effect second study diurnal glycemic excursions NIDDM patients h/day mg times/day similar drug min main meals meals acute insulinotropic action sulfonylurea drugs chronic continuous exposure acute extrapancreatic action exposure clinical benefit sulfonylurea min start meal 